Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Urology Reports
Published in: Current Urology Reports 8/2016

01-08-2016 | Benign Prostatic Hyperplasia (K McVary, Section Editor)

Trends in Simple Prostatectomy for Benign Prostatic Hyperplasia

Authors: Joseph J. Pariser, Vignesh T. Packiam, Melanie A. Adamsky, Gregory T. Bales

Published in: Current Urology Reports | Issue 8/2016

Login to get access

Abstract

The definitive treatment for symptomatic large volume (>80 mL) benign prostatic hyperplasia (BPH) is simple prostatectomy (SP). This can be performed by utilizing a retropubic, suprapubic, or a combined approach. The latter two approaches allow for the management of concomitant bladder diverticulum or stones through the same incision. Each approach affords unique technical strengths and weaknesses that must be considered in light of patient characteristics and concomitant pathology. SP allows for removal of the entire prostatic adenoma while obviating some of the neurovascular and continence issues that can arise from radical prostatectomy. Concerns with SP include its relatively high perioperative morbidity, notably bleeding. Therefore, there is increasing interest in less invasive options, including enucleation procedures and minimally invasive SP. This review presents an update regarding trends and outcomes of SP, as well as the effectiveness and popularity of alternative treatments.
Literature
1.••
Pariser JJ, Pearce SM, Patel SG, Bales GT. National Trends of Simple Prostatectomy for Benign Prostatic Hyperplasia With an Analysis of Risk Factors for Adverse Perioperative Outcomes. Urology. 2015;86:721–5. This manuscript represents the largest national database study regarding trends in the use of SP with a multivariate analysis of risk factors for complications.CrossRefPubMed
2.
Jones P, Alzweri L, Rai BP, Somani BK, Bates C, Aboumarzouk OM. Holmium laser enucleation versus simple prostatectomy for treating large prostates: results of a systematic review and meta-analysis. Arab J Urol. 2016;14:50–8.CrossRefPubMed
3.
Lee C, Kozlowski JM, Grayhack JT. Etiology of benign prostatic hyperplasia. Urol Clin N Am. 1995;22:237–46.
4.
Lee C, Kozlowski JM, Grayhack JT. Intrinsic and extrinsic factors controlling benign prostatic growth. Prostate. 1997;31:131–8.CrossRefPubMed
5.
Auffenberg GB, Helfand BT, McVary KT. Established medical therapy for benign prostatic hyperplasia. Urol Clin N Am. 2009;36:443–59.CrossRef
6.
McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care. 2006;12:S122–8.PubMed
7.
Wright EJ, Fang J, Metter EJ, Partin AW, Landis P, Chan DW, et al. Prostate specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore Longitudinal Study of Aging. J Urol. 2002;167:2484–7.CrossRefPubMed
8.
Blankstein U, Van Asseldonk B, Elterman DS. BPH update: medical versus interventional management. Can J Urol. 2016;23:10–5.PubMed
9.
Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Nandy I, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57:123–31.CrossRefPubMed
10.
Roehrborn CG, Barkin J, Siami P, Tubaro A, Wilson TH, Morrill BB, et al. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial. BJU Int. 2011;107:946–54.CrossRefPubMed
11.
McConnell JD, Roehrborn CG, Bautista OM, Andriole GL, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349:2387–98.CrossRefPubMed
12.
McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185:1793–803.CrossRefPubMed
13.
Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJMCH. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004;46:547–54.CrossRefPubMed
14.
Gee WF, Holtgrewe HL, Albertsen PC, Litwin MS, Manyak MJ, O’Leary MP, et al. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States. J Urol. 1995;154:205–6.CrossRefPubMed
15.
Bruskewitz R. Management of symptomatic BPH in the US: who is treated and how? Eur Urol. 1999;36 Suppl 3:7–13.CrossRefPubMed
16.
Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. 1989;320:1120–4.CrossRefPubMed
17.
Varkarakis I, Kyriakakis Z, Delis A, Protogerou V, Deliveliotis C. Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology. 2004;64:306–10.CrossRefPubMed
18.
Parsons JK, Rangarajan SS, Palazzi K, Chang D. A national, comparative analysis of perioperative outcomes of open and minimally invasive simple prostatectomy. J Endourol. 2015;29:919–24.CrossRefPubMed
19.
Chughtai BI, Simma-Chiang V, Lee R, Isaacs A, Te AE, Kaplan SA, et al. Trends and utilization of laser prostatectomy in ambulatory surgical procedures for the treatment of benign prostatic hyperplasia in New York State (2000–2011). J Endourol. 2015;29:700–6.CrossRefPubMed
20.••
Lowrance WT, Southwick A, Maschino AC, Sandhu JS. Contemporary practice patterns of endoscopic surgical management for benign prostatic hyperplasia among urologists in the United States. J Urol. 2013;189:1811–6. This study reports on the urologist-level practice patterns in the treatment of BPH. Notably, endoscopic laser procedures are gaining in popularity, especially with younger physicians.CrossRefPubMed
21.
Serretta V, Morgia G, Fondacaro L, Curto G. Lo bianco A, Pirritano D, et al. Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology. 2002;60:623–7.CrossRefPubMed
22.
Gratzke C, Schlenker B, Seitz M, Karl A, Hermanek P, Lack N, et al. Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol. 2007;177:1419–22.CrossRefPubMed
23.
Abrams PH, Shah PJ, Bryning K, Gaches CG, Ashken MH, Green NA. Blood loss during transurethral resection of the prostate. Anaesthesia. 1982;37:71–3.CrossRefPubMed
24.
Montesi L, Quaresima L, Tiroli M, Lacetera V, Cantoro U, Sbrollini G, et al. Improvement of lower urinary tract symptoms and sexual activity after open simple prostatectomy: prospective analysis of 50 cases. Arch Ital Urol Androl. 2014;86:353–5.CrossRefPubMed
25.•
Chen S, Zhu L, Cai J, Zheng Z, Ge R, Wu M, et al. Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 years. Eur Urol. 2014;66:284–91. This was a randomized trial of plasmakinetic enucleation and open prostatectomy. The enucleation procedure demonstrated similar long-term voiding outcomes with improved perioperative morbidity.CrossRefPubMed
26.
Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008;53:160–6.CrossRefPubMed
27.
Elshal AM, El-Nahas AR, Barakat TS, Elsaadany MM, El-Hefnawy AS. Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: perioperative outcomes of a contemporary series. Arab J Urol. 2013;11:362–8.CrossRefPubMedPubMedCentral
28.••
Autorino R, Zargar H, Mariano MB, Sanchez-Salas R, Sotelo RJ, Chlosta PL, et al. Perioperative Outcomes of robotic and laparoscopic simple prostatectomy: a European-American multi-institutional analysis. Eur Urol. 2015;68:86–94. This is a very large multi-institutional study regarding the perioperative outcomes of minimally invasive simple prostatectomy. They demonstrate good outcomes of the procedure across multiple centers.CrossRefPubMed
29.
Humphreys M, Miller N, Handa S, Terry C, Munch L, Lingeman J. Holmium laser enucleation of the prostate—outcomes independent of prostate size? J Urol. 2008;180:2431–5.CrossRefPubMed
30.
Geavlete B, Stanescu F, Iacoboaie C, Geavlete P. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases—a medium term, prospective, randomized comparison. BJU Int. 2013;111:793–803.CrossRefPubMed
31.
Sivarajan G, Borofsky MS, Shah O, Lingeman JE, Lepor H. The Role of Minimally Invasive Surgical Techniques in the Management of Large-gland Benign Prostatic Hypertrophy. Rev Urol. 2015;17:140–9.PubMedPubMedCentral
32.
Salonia A, Suardi N, Naspro R, Mazzoccoli B, Zanni G, Gallina A, et al. Holmium laser enucleation versus open prostatectomy for benign prostatic hyperplasia: an inpatient cost analysis. Urology. 2006;68:302–6.CrossRefPubMed
33.•
Gross AJ, Netsch C, Knipper S, Hölzel J, Bach T. Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol. 2013;63:859–67. This is a very large study (n = 1080) regarding thulium laser vapoenucleation of the prostate and perioperative outcomes with improvements in complication rates seen throughout their experience.CrossRefPubMed
34.
El-Hakim A, Elhilali MM. Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int. 2002;90:863–9.CrossRefPubMed
35.
Shah HN, Mahajan AP, Sodha HS, Hegde S, Mohile PD, Bansal MB. Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol. 2007;177:1468–74.CrossRefPubMed
36.
Mariano MB, Graziottin TM, Tefilli MV. Laparoscopic prostatectomy with vascular control for benign prostatic hyperplasia. J Urol. 2002;167:2528–9.CrossRefPubMed
37.•
Pavan N, Zargar H, Sanchez-Salas R, Castillo O, Celia A, Gallo G, et al. Robot-assisted versus standard laparoscopy for simple prostatectomy: multicenter comparative outcomes. Urology. 2016 (in press). This is a comparative analysis of robotic and laparoscopic simple prostatectomy across multiple centers. Both procedures were safe approaches to treat BPH in very large glands.
38.
Baumert H, Ballaro A, Dugardin F, Kaisary AV. Laparoscopic versus open simple prostatectomy: a comparative study. J Urol. 2006;175:1691–4.CrossRefPubMed
39.
McCullough TC, Heldwein FL, Soon SJ, Galiano M, Barret E, Cathelineau X, et al. Laparoscopic versus open simple prostatectomy: an evaluation of morbidity. J Endourol. 2009;23:129–33.CrossRefPubMed
Metadata
Title
Trends in Simple Prostatectomy for Benign Prostatic Hyperplasia
Authors
Joseph J. Pariser
Vignesh T. Packiam
Melanie A. Adamsky
Gregory T. Bales
Publication date
01-08-2016
Publisher
Springer US
Published in
Current Urology Reports / Issue 8/2016
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-016-0610-6

Other articles of this Issue 8/2016

Current Urology Reports 8/2016 Go to the issue

New Imaging Techniques (A Rastinehad and S Rais-Bahrami, Section Editors)

3-D Imaging and Simulation for Nephron Sparing Surgical Training

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

How to Avoid and Deal with Pelvic Mesh Litigation

New Imaging Techniques (A Rastinehad and S Rais-Bahrami, Section Editors)

Three-Dimensional Imaging of Urethral Stricture Disease and Urethral Pathology for Operative Planning

Men’s Health (A Dabaja, Section Editor)

Hormone-Based Treatments in Subfertile Males

New Imaging Techniques (A Rastinehad and S Rais-Bahrami, Section Editors)

Ablative Therapies for the Treatment of Small Renal Masses: a Review of Different Modalities and Outcomes